Concepedia

Beatriz Martins

BM

Statistics

Publications

19

Citations

771

H-Index

16

Active since

2018

Affiliations

University of Helsinki(Current)

University of Naples Federico II

Karolinska Institutet

Helsinki University Hospital

Helsinki Institute of Physics

Beatriz Martins is an author at University of Helsinki specializing in oncology, cancer immunology, and cancer immunotherapy.

ORCID

Publications per year

2018–2023

19

Publications

19

Artificially cloaked viral nanovaccine for cancer immunotherapy

Manlio Fusciello, Flavia Fontana, Siri Tähtinen et al. · Nature Communications · 2019 · 137 citations · Full text

, , +17

FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis

S. Pauliina Turunen, Pernilla von Nandelstadh, Tiina Öhman et al. · Cell Death and Differentiation · 2019 · 64 citations · Full text

, , +17

Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy

Siri Tähtinen, Sara Feola, Cristian Capasso et al. · Cancer Research · 2020 · 57 citations

, , +17

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 53 citations · Full text

, , +17

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

Erkko Ylösmäki, Leena Ylösmäki, Manlio Fusciello et al. · Molecular Therapy — Oncolytics · 2021 · 52 citations · Full text

, , +17

1–5 of 19